•
Dec 31, 2023

ClearPoint Neuro Q4 2023 Earnings Report

Reported record revenue and reduced quarterly cash burn.

Key Takeaways

ClearPoint Neuro reported a record revenue of $6.8 million for Q4 2023, a 32% increase year-over-year, and a reduced quarterly cash burn to $1.2 million. The company reaffirmed its 2024 revenue guidance to be between $28.0 million and $32.0 million.

Reported Q4 2023 revenue of $6.8 million, a 32% year-over-year increase.

Cash burn of $1.2 million in Q4, bringing cash and cash equivalents to $23.1 million as of December 31, 2023.

Six new hospital customers already added since the beginning of the year.

Received 510(k) clearance for Smartframe OR™ Stereotactic System.

Total Revenue
$6.81M
Previous year: $5.17M
+31.6%
EPS
-$0.19
Previous year: -$0.18
+5.6%
Gross Profit
$4.01M
Previous year: $3.32M
+21.0%
Cash and Equivalents
$23.1M
Previous year: $27.6M
-16.2%
Free Cash Flow
-$1.19M
Previous year: -$3.1M
-61.7%
Total Assets
$42.7M
Previous year: $55.5M
-23.1%

ClearPoint Neuro

ClearPoint Neuro

ClearPoint Neuro Revenue by Segment

Forward Guidance

ClearPoint Neuro reaffirms its 2024 revenue guidance to be in the range of $28.0 million - $32.0 million.